Roth J - Search Results

1

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer.

Federico L, McGrail DJ, Bentebibel SE, Haymaker C, Ravelli A, Forget MA, Karpinets T, Jiang P, Reuben A, Negrao MV, Li J, Khairullah R, Zhang J, Weissferdt A, Vaporciyan AA, Antonoff MB, Walsh G, Lin SY, Futreal A, Wistuba I, Roth J, Byers LA, Gaudreau PO, Uraoka N, Cruz AF, Dejima H, Lazcano RN, Solis LM, Parra ER, Lee JJ, Swisher S, Cascone T, Heymach JV, Zhang J, Sepesi B, Gibbons DL, Bernatchez C. Federico L, et al. Among authors: roth j. Ann Oncol. 2022 Jan;33(1):42-56. doi: 10.1016/j.annonc.2021.09.021. Epub 2021 Oct 13. Ann Oncol. 2022. PMID: 34653632 Free PMC article.

2

Prognostic significance of computed tomography in resected N2 lung cancer.

Cybulsky IJ, Lanza LA, Ryan MB, Putnam JB Jr, McMurtrey MM, Roth JA. Cybulsky IJ, et al. Among authors: roth ja. Ann Thorac Surg. 1992 Sep;54(3):533-7. doi: 10.1016/0003-4975(92)90449-e. Ann Thorac Surg. 1992. PMID: 1324657

3

Combination immunotherapy for advanced lung cancer.

Yang SC, Grimm EA, Roth JA. Yang SC, et al. Among authors: roth ja. J Natl Cancer Inst Monogr. 1992;(13):197-201. J Natl Cancer Inst Monogr. 1992. PMID: 1327033 Clinical Trial.

4

Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer.

Putnam EA, Yen N, Gallick GE, Steck PA, Fang K, Akpakip B, Gazdar AF, Roth JA. Putnam EA, et al. Among authors: roth ja. Surg Oncol. 1992 Feb;1(1):49-60. doi: 10.1016/0960-7404(92)90056-q. Surg Oncol. 1992. PMID: 1341235

5

New approaches to treating early lung cancer.

Roth JA. Roth JA. Cancer Res. 1992 May 1;52(9 Suppl):2652s-2657s. Cancer Res. 1992. PMID: 1562995 Review.

6

Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.

Yang SC, Grimm EA, Parkinson DR, Carinhas J, Fry KD, Mendiguren-Rodriguez A, Licciardello J, Owen-Schaub LB, Hong WK, Roth JA. Yang SC, et al. Among authors: roth ja. Cancer Res. 1991 Jul 15;51(14):3669-76. Cancer Res. 1991. PMID: 1648441 Clinical Trial.

7

Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).

Zatopek NK, Holoye PY, Ellerbroek NA, Hong WK, Roth JA, Ryan MB, Komaki R, Pang AC, Glisson BS. Zatopek NK, et al. Among authors: roth ja. Am J Clin Oncol. 1991 Oct;14(5):427-32. doi: 10.1097/00000421-199110000-00013. Am J Clin Oncol. 1991. PMID: 1659177

8

Phenotype and cytolytic activity of mouse tumor-bearer splenocytes and tumor-infiltrating lymphocytes from K-1735 melanoma metastases following anti-CD3, interleukin-2, and tumor necrosis factor-alpha combination immunotherapy.

Yang SC, Fry KD, Grimm EA, Roth JA. Yang SC, et al. Among authors: roth ja. J Immunother (1991). 1991 Oct;10(5):326-35. doi: 10.1097/00002371-199110000-00004. J Immunother (1991). 1991. PMID: 1790140

9

Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha.

Yang SC, Owen-Schaub L, Mendiguren-Rodriguez A, Grimm EA, Hong WK, Roth JA. Yang SC, et al. Among authors: roth ja. J Thorac Cardiovasc Surg. 1990 Jan;99(1):8-12; discussion 12-3. J Thorac Cardiovasc Surg. 1990. PMID: 2152954

10

Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.

Schneider PM, Hung MC, Chiocca SM, Manning J, Zhao XY, Fang K, Roth JA. Schneider PM, et al. Among authors: roth ja. Cancer Res. 1989 Sep 15;49(18):4968-71. Cancer Res. 1989. PMID: 2569928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,864 results

Search Page